Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Dianthus Therapeutics Stock (NASDAQ: DNTH) stock price, news, charts, stock research, profile.
You can purchase shares of Dianthus Therapeutics (NASDAQ:DNTH) through any online brokerage.
Other companies in Dianthus Therapeutics’s space includes: Immunome (NASDAQ:IMNM), Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Upstream Bio (NASDAQ:UPB) and Altimmune (NASDAQ:ALT).
Dianthus Therapeutics has a consensus price target of $46.43.
The stock price for Dianthus Therapeutics (NASDAQ: DNTH) is $20 last updated January 17, 2025 at 4:00 PM EST.
There are no upcoming dividends for Dianthus Therapeutics.
Dianthus Therapeutics’s Q4 earnings are confirmed for Thursday, March 20, 2025.
There is no upcoming split for Dianthus Therapeutics.
Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.